Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol

被引:156
作者
Basly, JP [1 ]
Marre-Fournier, F [1 ]
Le Bail, JC [1 ]
Habrioux, G [1 ]
Chulia, AJ [1 ]
机构
[1] UFR Pharm, UPRES EA 1085, F-87025 Limoges, France
关键词
resveratrol; estrogens; human breast cancer cell lines; scavenging properties;
D O I
10.1016/S0024-3205(99)00650-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Resveratrol, natural compound found in grapes and wine, has been reported to have a variety of health benefit properties. Based on the structural similarity to the synthetic estrogen diethylstilbestrol, we investigated estrogenic/antiestrogenic effects on human breast cancer cell lines, MCF-7 and MVLN, and scavenging properties using DPPH of both (E)- and (Z)-isomers. Both isomers increased the in vitro growth of MCF-7 cell lines at medium concentrations (10 and 25 mu M) whereas the low concentrations (0.1 and 1 mu M) had no effect and the high concentration (50 mu M) decreased the cell growth and was cytotoxic. The 25 mu M (E)-isomer alone was able to reduced the proliferation induced by the estradiol.-low concentrations of (E)- and (Z)-resveratrol (0.1 and 1 mu M) and medium concentration 10 mu M (Z)-resveratrol did not interfere with the estrogen receptor. In contrast, medium concentrations of (E)-resveratrol (10 and 25 mu M) and (Z)-resveratrol (25 mu M) functioned as superagonists of estradiol. Whatever the model used, MCF-7 or MVLN cell lines, (Z)-resveratrol was less effective than (E)-resveratrol. Extinction of DPPH and Fe(III) reduction experiments showed that both isomers of resveratrol could act as free radicals scavengers or pro-oxidant compounds. The properties of low concentrations of resveratrol raise the possibility that structure-function studies could lead to the development of more selective estrogen receptor agonists and antagonists, which could be useful as a therapeutic agent.
引用
收藏
页码:769 / 777
页数:9
相关论文
共 23 条
  • [1] Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidants
    Ancerewicz, J
    Migliavacca, E
    Carrupt, PA
    Testa, B
    Brée, F
    Zini, R
    Tillement, JP
    Labidalle, S
    Guyot, D
    Chauvet-Monges, AM
    Crevat, A
    Le Ridant, A
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (01) : 113 - 120
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Clément MV, 1998, BLOOD, V92, P996
  • [4] Decker EA, 1997, NUTR REV, V55, P396, DOI 10.1111/j.1753-4887.1997.tb01580.x
  • [5] STUDY OF AN ANTIESTROGENIC EFFECT OF RETINOIC ACID IN MCF-7 CELLS
    DEMIRPENCE, E
    PONS, M
    BALAGUER, P
    GAGNE, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) : 100 - 106
  • [6] DEMIRPENCE E, 1994, CANCER RES, V54, P1458
  • [7] Resveratrol, a remarkable inhibitor of ribonucleotide reductase
    Fontecave, M
    Lepoivre, M
    Elleingand, E
    Gerez, C
    Guittet, O
    [J]. FEBS LETTERS, 1998, 421 (03) : 277 - 279
  • [8] INHIBITION OF OXIDATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY PHENOLIC SUBSTANCES IN RED WINE
    FRANKEL, EN
    KANNER, J
    GERMAN, JB
    PARKS, E
    KINSELLA, JE
    [J]. LANCET, 1993, 341 (8843) : 454 - 457
  • [9] Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
    Gehm, BD
    McAndrews, JM
    Chien, PY
    Jameson, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 14138 - 14143
  • [10] Method to assay the concentrations of phenolic constituents of biological interest in wines
    Goldberg, DM
    Tsang, E
    Karumanchiri, A
    Diamandis, EP
    Soleas, G
    Ng, E
    [J]. ANALYTICAL CHEMISTRY, 1996, 68 (10) : 1688 - 1694